Cargando…

Development and validation of the Japanese version of the Hyperarousal Scale

BACKGROUND: The objectives of this study were to develop a Japanese version of the Hyperarousal Scale (HAS-J) and investigate its factor structure, reliability, and validity, as well as to calculate a cutoff score for the HAS-J and assess different levels of hyperarousal in insomnia patients and com...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayabe, Naoko, Nakajima, Shun, Okajima, Isa, Inada, Ken, Yamadera, Wataru, Yamashita, Hidehisa, Tachimori, Hisateru, Kamei, Yuichi, Takeshima, Masahiro, Inoue, Yuichi, Mishima, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484233/
https://www.ncbi.nlm.nih.gov/pubmed/36123639
http://dx.doi.org/10.1186/s12888-022-04243-0
_version_ 1784791837799612416
author Ayabe, Naoko
Nakajima, Shun
Okajima, Isa
Inada, Ken
Yamadera, Wataru
Yamashita, Hidehisa
Tachimori, Hisateru
Kamei, Yuichi
Takeshima, Masahiro
Inoue, Yuichi
Mishima, Kazuo
author_facet Ayabe, Naoko
Nakajima, Shun
Okajima, Isa
Inada, Ken
Yamadera, Wataru
Yamashita, Hidehisa
Tachimori, Hisateru
Kamei, Yuichi
Takeshima, Masahiro
Inoue, Yuichi
Mishima, Kazuo
author_sort Ayabe, Naoko
collection PubMed
description BACKGROUND: The objectives of this study were to develop a Japanese version of the Hyperarousal Scale (HAS-J) and investigate its factor structure, reliability, and validity, as well as to calculate a cutoff score for the HAS-J and assess different levels of hyperarousal in insomnia patients and community dwellers. METHODS: We recruited 224 outpatients receiving insomnia treatment (56.3% women; mean age 51.7 ± 15.6 years) and 303 community dwellers aged 20 years or older (57.8% women; mean age 43.9 ± 15.2 years). Exploratory and confirmatory factor analysis was performed to examine the factor structure of the HAS-J. Cronbach’s α and McDonald’s ω were then used to test internal consistency. To examine the scale’s validity, we determined correlations between the HAS-J and other indexes and compared HAS-J scores between insomnia patients and community dwellers. We also compared HAS-J scores between two community-dweller groups (normal and poor sleepers) and two insomnia patient groups (with and without alleviation after treatment). RESULTS: Following exploratory and confirmatory factor analysis, a 20-item measure emerged comprising three factors: “Introspectiveness and Reactivity,” “Neuroticism,” and “Insomnia.” Confirmatory factor analysis showed a generally good fit for the model of the three-factor structure suggested by the exploratory factor analysis loadings (χ(2) (163) = 327.423, (p <  0.001), CFI = 0.914, GFI = 0.872, AGFI = 0.835, RMSEA = 0.067). In insomnia patients, internal consistency indicated sufficient reliability of the HAS-J. Correlation analysis showed weak to moderate positive correlations of the HAS-J score with other indexes, indicating concurrent validity of the HAS-J. All HAS-J subscale scores were significantly higher in insomnia patients than in community dwellers. Additionally, the total score in patients with alleviation of insomnia was comparable to that in poor sleepers and significantly higher than that in normal sleepers. CONCLUSIONS: This study demonstrated the reliability and validity of the HAS-J, indicating that it is useful as a clinical scale of hyperarousal. The high level of hyperarousal in insomnia patients who were assessed to be in remission by the Insomnia Severity Index suggests a risk of insomnia recurrence in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-04243-0.
format Online
Article
Text
id pubmed-9484233
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94842332022-09-20 Development and validation of the Japanese version of the Hyperarousal Scale Ayabe, Naoko Nakajima, Shun Okajima, Isa Inada, Ken Yamadera, Wataru Yamashita, Hidehisa Tachimori, Hisateru Kamei, Yuichi Takeshima, Masahiro Inoue, Yuichi Mishima, Kazuo BMC Psychiatry Research BACKGROUND: The objectives of this study were to develop a Japanese version of the Hyperarousal Scale (HAS-J) and investigate its factor structure, reliability, and validity, as well as to calculate a cutoff score for the HAS-J and assess different levels of hyperarousal in insomnia patients and community dwellers. METHODS: We recruited 224 outpatients receiving insomnia treatment (56.3% women; mean age 51.7 ± 15.6 years) and 303 community dwellers aged 20 years or older (57.8% women; mean age 43.9 ± 15.2 years). Exploratory and confirmatory factor analysis was performed to examine the factor structure of the HAS-J. Cronbach’s α and McDonald’s ω were then used to test internal consistency. To examine the scale’s validity, we determined correlations between the HAS-J and other indexes and compared HAS-J scores between insomnia patients and community dwellers. We also compared HAS-J scores between two community-dweller groups (normal and poor sleepers) and two insomnia patient groups (with and without alleviation after treatment). RESULTS: Following exploratory and confirmatory factor analysis, a 20-item measure emerged comprising three factors: “Introspectiveness and Reactivity,” “Neuroticism,” and “Insomnia.” Confirmatory factor analysis showed a generally good fit for the model of the three-factor structure suggested by the exploratory factor analysis loadings (χ(2) (163) = 327.423, (p <  0.001), CFI = 0.914, GFI = 0.872, AGFI = 0.835, RMSEA = 0.067). In insomnia patients, internal consistency indicated sufficient reliability of the HAS-J. Correlation analysis showed weak to moderate positive correlations of the HAS-J score with other indexes, indicating concurrent validity of the HAS-J. All HAS-J subscale scores were significantly higher in insomnia patients than in community dwellers. Additionally, the total score in patients with alleviation of insomnia was comparable to that in poor sleepers and significantly higher than that in normal sleepers. CONCLUSIONS: This study demonstrated the reliability and validity of the HAS-J, indicating that it is useful as a clinical scale of hyperarousal. The high level of hyperarousal in insomnia patients who were assessed to be in remission by the Insomnia Severity Index suggests a risk of insomnia recurrence in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-04243-0. BioMed Central 2022-09-19 /pmc/articles/PMC9484233/ /pubmed/36123639 http://dx.doi.org/10.1186/s12888-022-04243-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ayabe, Naoko
Nakajima, Shun
Okajima, Isa
Inada, Ken
Yamadera, Wataru
Yamashita, Hidehisa
Tachimori, Hisateru
Kamei, Yuichi
Takeshima, Masahiro
Inoue, Yuichi
Mishima, Kazuo
Development and validation of the Japanese version of the Hyperarousal Scale
title Development and validation of the Japanese version of the Hyperarousal Scale
title_full Development and validation of the Japanese version of the Hyperarousal Scale
title_fullStr Development and validation of the Japanese version of the Hyperarousal Scale
title_full_unstemmed Development and validation of the Japanese version of the Hyperarousal Scale
title_short Development and validation of the Japanese version of the Hyperarousal Scale
title_sort development and validation of the japanese version of the hyperarousal scale
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484233/
https://www.ncbi.nlm.nih.gov/pubmed/36123639
http://dx.doi.org/10.1186/s12888-022-04243-0
work_keys_str_mv AT ayabenaoko developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT nakajimashun developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT okajimaisa developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT inadaken developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT yamaderawataru developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT yamashitahidehisa developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT tachimorihisateru developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT kameiyuichi developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT takeshimamasahiro developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT inoueyuichi developmentandvalidationofthejapaneseversionofthehyperarousalscale
AT mishimakazuo developmentandvalidationofthejapaneseversionofthehyperarousalscale